Observational studyPharmacology research & perspectives2023

Application of physiologically based pharmacokinetic modeling to understand real-world outcomes in patients receiving imatinib for chronic myeloid leukemia.

Josephine A Adattini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.